Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 3, 2006, Pages 343-348

  Garcia, Joaquin J ^a   Kramer, Miranda J ^b   Mackey, Zachary B ^a   O'Donnell, Richard J ^b   Horvai, Andrew E ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CELL MEMBRANE; CHROMOSOME 12; CHROMOSOME 22; CHROMOSOME TRANSLOCATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MELANOMA; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE TUMOR; TUMOR DIFFERENTIATION;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 22; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, CLEAR CELL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 33644967313     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Enzinger FM. Clear cell sarcoma of the tendons and aponeuroses: an analysis of 21 cases. Cancer. 1965;18:1163-1174.
2. Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassessment of clear cell sarcoma. Am J Surg Pathol 1983;7:403-413.
3. Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol. 2001;14:6-9.
4. Kindblom LG, Lodding P, Angervall L. Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch A Pathol Anat Histopathol. 1983;401: 109-128.
5. Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol. 1992;16:1197-1204.
6. Montgomery EA, Meis JM, Ramos AG, Frisman D, Mertz K. Clear cell sarcoma of tendons and aponeuroses: a clinicopathological study of 58 cases with analysis of prognostic factors. Int J Surg Pathol. 1993;1:89-100.
7. Swanson PE, Wick MR. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med. 1989;113:55-60.
8. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF1 gene fusion induced by t(12,22) translocation in malignant melanoma of soft parts. Nat Genet. 1993;4:341-345.
9. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene. 1996; 12:159-167.
10. Fujimura Y, Siddique H, Lee L, Rao VN, Reddy ES. EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene. 2001;20: 6653-6659.
11. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene. 1994;9:3087-3097.
12. Antonescu CR, Tshernyavsky SS, Woodruff JM, et al. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Molec Diagn. 2002;4: 44-52.
13. Speleman F, Delattre O, Peter M, Hauben E, Van Roy N, Van Marck E. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Mod Pathol. 1997;10: 496-499.
14. Pellin A. New type of chimeric fusion product between the EWS and ATF1 genes in clear cell sarcoma (malignant melanoma of soft parts). Genes Chromosomes Cancer. 1998;23:358-360.
15. Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer. 2001;84:535-538.
16. Fukuda T, Kakihara T, Baba K, Yamaki T, Yamaguchi T, Suzuki T. Clear cell sarcoma arising in the transverse colon. Pathol Int. 2000;50:412-416.
17. OhbaY, Suzuki H, Hiraga H, et al. Melanotic peritoneal sarcomatosis originating from clear cell sarcoma. Pathol Int. 1999;49:653-657.
18. Sonobe H, Takeuchi T, Taguchi T, et al. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13; q12) translocation and hybrid EWS/ATF-1 transcript. J Pathol. 1999;187:594-597.
19. Panagopoulos I, Mertens F, Debiec-Rychler M, et al. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Intl Cancer. 2002;99:560-567.
20. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res. 1992;52:6139-6143.
21. Zakut R, Perlis R, Eliyahu S, et al. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene. 1993;8:2221-2229.
22. Gutman M, Singh RK, Radinsky R, Bar-Eli M. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res. 1994;14(5A):1759-1765.
23. Bar-Eli M. Molecular mechanisms of melanoma metastasis. J Cell Physiol. 1997;173:275-278.
24. Takahashi H, Saitoh K, Kishi H, Parsons PG. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours. Virchows Arch. 1995;427:283-288.
25. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117: 188-193.
26. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728-734.
27. Argani P, Perez-Ordonez B, Xiao H, Caruana SM, Huvos AC, Ladanyi M. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol. 1998;22:391-398.
28. Horvai AE, Li L, Xu Z, Kramer MJ, Jablons DM, Treseler PA. c-Kit is not expressed in malignant mesothelioma. Mod Pathol. 2003;16:818-822.
29. Kuiper DR, Hoekstra HJ, Veth RP, Wobbes T. The management of clear cell sarcoma. Eur J Surg Oncol. 2003;29:568-570.
30. Kinnaert E, Morandini R, Simon S, Hill HZ, Ghanem G, Van Houtte P. The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiat Res. 2000;154:497-502.
31. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29:498-504.
32. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13:1134-1142.
33. Shen SS, Zhang PS, Eton O, Prieto VG. Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array. J Cutan Pathol. 2003;30:539-547.
34. Luca MR, Bar-Eli M. Molecular changes in human melanoma metastasis. Histol Histopathol. 1998;13:1225-1231.